101 - Patients with Carbapenem-resistant Klebsiella aerogenes and Enterobacter cloacae complex Colonization or Infection Have Different Baseline Characteristics but Similar Mortality and Clinical Outcomes

Thursday, October 17, 2024

11:15 AM – 11:30 AM US PT

Location: 403 A

Presenting Author(s)

John P. Franzone, MD

Clinical Fellow
University of North Carolina at Chapel Hill
Apex, NC, United States

Slides

Co-Author(s)

WS

Wanying Shao, M.S.

George Washington University
Rockville, Maryland, United States
LK

Lauren Komarow, MS

Biostatistician
George Washington University
Rockville, Maryland, United States
Jesse T. Jacob, MD

Professor of Medicine
Emory University School of Medicine
Atlanta, GA, United States
Michael J. Satlin, MD

Associate Professor
Weill Cornell Medicine
New York, NY, United States
Keith S. Kaye, MD, MPH

Professor of Medicine
Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ, United States
Blake M. Hanson, MS, PhD

Assistant Professor
The University of Texas Health Science Center
Houston, Texas, United States
Gregory D. Weston, MD, MSCR

Assistant Professor
Montefiore Medical Center and Albert Einstein College of Medicine
Bronx, NY, United States
Bettina F. Fries, MD, FIDSA

Chief, Division of Infectious Diseases
Renaissance School of Medicine at Stony Brook University
Stony Brook, NY, United States
EC

Eric Cober, MD

Staff
Cleveland Clinic Foundation
Cleveland, OH, United States
SD

Sorabh Dhar, MD, FIDSA

Professor of Medicine
Wayne State University/Detroit Medical Center, John Dingell VAMC
Detroit, Michigan, United States
JJ

Jianping Jiang, n/a

Center for Discovery and Innovation, Hackensack Meridian Health
Nutley, New Jersey, United States
LC

Liang Chen, MD Ph.D.

University of Buffalo
Buffalo, New York, United States
CH

Carol Hill, PhD

Duke Clinical Research Institute
Durham, North Carolina, United States
Angelique E. Boutzoukas, MD

Fellow, Pediatric Infectious Diseases
Duke University School of Medicine
Durham, North Carolina, United States
Tessa Andermann, MD, MPH (she/her/hers)

Assistant Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States
David van Duin, MD, PhD

Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States

Disclosure(s):

John P. Franzone, MD: No financial relationships to disclose

Wanying Shao, M.S.: No financial relationships to disclose

Lauren Komarow, MS: No financial relationships to disclose

Jesse T. Jacob, MD: No financial relationships to disclose

Michael J. Satlin, MD: AbbVie: DSMB participant; bioMerieux: Grant/Research Support; Merck: Grant/Research Support; Selux Diagnostics: Grant/Research Support; SNIPRBiome: Grant/Research Support

Keith S. Kaye, MD, MPH: Allecra: Advisor/Consultant; CARB-X: Advisor/Consultant; GSK: Advisor/Consultant; Merck: Advisor/Consultant; Shionogi: Advisor/Consultant; Spero: Advisor/Consultant

Blake M. Hanson, MS, PhD: No financial relationships to disclose

Gregory D. Weston, MD, MSCR: No financial relationships to disclose

Bettina F. Fries, MD, FIDSA: No financial relationships to disclose

Eric Cober, MD: No financial relationships to disclose

Sorabh Dhar, MD, FIDSA: No financial relationships to disclose

Jianping Jiang, n/a: No financial relationships to disclose

Liang Chen, MD Ph.D.: No financial relationships to disclose

Carol Hill, PhD: Glaxo SmithKline: Retirement Health, Cash Balance Plan, Stocks/Bonds (Public Company)

Angelique E. Boutzoukas, MD: No financial relationships to disclose

Tessa Andermann, MD, MPH: No financial relationships to disclose

David van Duin, MD, PhD: Merck: Advisor/Consultant (), Grant/Research Support (); Pfizer: Advisor/Consultant (); Qpex: Advisor/Consultant (); Roche: Advisor/Consultant (); Shionogi: Advisor/Consultant (), Grant/Research Support ()